Literature DB >> 26179750

TIME management by medicinal larvae.

David I Pritchard1, Václav Čeřovský2, Yamni Nigam3, Samantha F Pickles1, Gwendolyn Cazander4, Peter H Nibbering5, Anke Bültemann6, Wilhelm Jung7.   

Abstract

Wound bed preparation (WBP) is an integral part of the care programme for chronic wounds. The acronym TIME is used in the context of WBP and describes four barriers to healing in chronic wounds; namely, dead Tissue, Infection and inflammation, Moisture imbalance and a non-migrating Edge. Larval debridement therapy (LDT) stems from observations that larvae of the blowfly Lucilia sericata clean wounds of debris. Subsequent clinical studies have proven debriding efficacy, which is likely to occur as a result of enzymatically active alimentary products released by the insect. The antimicrobial, anti-inflammatory and wound healing activities of LDT have also been investigated, predominantly in a pre-clinical context. This review summarises the findings of investigations into the molecular mechanisms of LDT and places these in context with the clinical concept of WBP and TIME. It is clear from these findings that biotherapy with L. sericata conforms with TIME, through the enzymatic removal of dead tissue and its associated biofilm, coupled with the secretion of defined antimicrobial peptides. This biotherapeutic impact on the wound serves to reduce inflammation, with an associated capacity for an indirect effect on moisture imbalance. Furthermore, larval serine proteinases have the capacity to alter fibroblast behaviour in a manner conducive to the formation of granulation tissue.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic wound; Infection; Larval debridement therapy; TIME; Tissue regeneration

Mesh:

Year:  2015        PMID: 26179750      PMCID: PMC7950164          DOI: 10.1111/iwj.12457

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  75 in total

1.  Lucifensin II, a defensin of medicinal maggots of the blowfly Lucilia cuprina (Diptera: Calliphoridae).

Authors:  Baydaa El Shazely; V Veverka; V Fucík; Z Voburka; J Zdárek; V Cerovský
Journal:  J Med Entomol       Date:  2013-05       Impact factor: 2.278

Review 2.  Preparing the wound bed--debridement, bacterial balance, and moisture balance.

Authors:  R G Sibbald; D Williamson; H L Orsted; K Campbell; D Keast; D Krasner; D Sibbald
Journal:  Ostomy Wound Manage       Date:  2000-11       Impact factor: 2.629

3.  The anti-microbial activity of maggot secretions: results of a preliminary study.

Authors:  S Thomas; A M Andrews; N P Hay; S Bourgoise
Journal:  J Tissue Viability       Date:  1999-10       Impact factor: 2.932

4.  Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds.

Authors:  Annie G Smith; Rachel A Powis; David I Pritchard; Stephen T Britland
Journal:  Biotechnol Prog       Date:  2006 Nov-Dec

5.  Induction of antibacterial activity in larvae of the blowfly Lucilia sericata by an infected environment.

Authors:  T Kawabata; H Mitsui; K Yokota; K Ishino; K Oguma; S Sano
Journal:  Med Vet Entomol       Date:  2010-10-14       Impact factor: 2.739

6.  In vitro antibacterial activity of Lucilia sericata maggot secretions.

Authors:  G Daeschlein; K Y Mumcuoglu; O Assadian; B Hoffmeister; A Kramer
Journal:  Skin Pharmacol Physiol       Date:  2006-12-13       Impact factor: 3.479

7.  Activity of antibacterial protein from maggots against Staphylococcus aureus in vitro and in vivo.

Authors:  Zhen Zhang; Jiangning Wang; Bo Zhang; Huanran Liu; Wei Song; Jiao He; Decheng Lv; Shouyu Wang; Xiaoguang Xu
Journal:  Int J Mol Med       Date:  2013-03-05       Impact factor: 4.101

8.  Lucimycin, an antifungal peptide from the therapeutic maggot of the common green bottle fly Lucilia sericata.

Authors:  Anne-Kathrin Pöppel; Aline Koch; Karl-Heinz Kogel; Heiko Vogel; Christian Kollewe; Jochen Wiesner; Andreas Vilcinskas
Journal:  Biol Chem       Date:  2014-06       Impact factor: 3.915

9.  The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.

Authors:  L Gilead; K Y Mumcuoglu; A Ingber
Journal:  J Wound Care       Date:  2012-02       Impact factor: 2.072

10.  Maggot debridement: an alternative method for debridement.

Authors:  Finn Gottrup; Bo Jørgensen
Journal:  Eplasty       Date:  2011-07-12
View more
  2 in total

1.  What is the optimal treatment time for larval therapy? A study on incubation time and tissue debridement by bagged maggots of the greenbottle fly, Lucilia sericata.

Authors:  Michael R Wilson; Yamni Nigam; John Knight; David I Pritchard
Journal:  Int Wound J       Date:  2018-10-31       Impact factor: 3.315

2.  Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots.

Authors:  Zdeněk Franta; Heiko Vogel; Rüdiger Lehmann; Oliver Rupp; Alexander Goesmann; Andreas Vilcinskas
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.